BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 111 filers reported holding BIODELIVERY SCIENCES INTL IN in Q2 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,468,000 | +4.4% | 473,550 | +21.6% | 0.00% | – |
Q3 2021 | $1,406,000 | +10.1% | 389,564 | +9.1% | 0.00% | – |
Q2 2021 | $1,277,000 | -21.8% | 356,933 | -14.6% | 0.00% | – |
Q1 2021 | $1,634,000 | -10.4% | 417,894 | -3.7% | 0.00% | – |
Q4 2020 | $1,823,000 | +43.3% | 434,064 | +27.2% | 0.00% | – |
Q3 2020 | $1,272,000 | -15.8% | 341,136 | -1.5% | 0.00% | – |
Q2 2020 | $1,510,000 | +21.1% | 346,205 | +5.2% | 0.00% | – |
Q1 2020 | $1,247,000 | -56.8% | 329,153 | -28.0% | 0.00% | -100.0% |
Q4 2019 | $2,889,000 | +217.8% | 457,183 | +111.7% | 0.00% | – |
Q3 2019 | $909,000 | -45.9% | 215,978 | -40.2% | 0.00% | – |
Q2 2019 | $1,680,000 | +62.3% | 361,198 | +85.0% | 0.00% | – |
Q1 2019 | $1,035,000 | +531.1% | 195,264 | +341.0% | 0.00% | – |
Q4 2018 | $164,000 | +32.3% | 44,280 | 0.0% | 0.00% | – |
Q3 2018 | $124,000 | -5.3% | 44,280 | -0.0% | 0.00% | – |
Q2 2018 | $131,000 | +10.1% | 44,281 | -15.7% | 0.00% | – |
Q1 2018 | $119,000 | -9.8% | 52,559 | +17.7% | 0.00% | – |
Q4 2017 | $132,000 | +0.8% | 44,668 | +0.9% | 0.00% | – |
Q3 2017 | $131,000 | +5.6% | 44,280 | 0.0% | 0.00% | – |
Q2 2017 | $124,000 | +47.6% | 44,280 | 0.0% | 0.00% | – |
Q1 2017 | $84,000 | +7.7% | 44,280 | -0.7% | 0.00% | – |
Q4 2016 | $78,000 | -54.1% | 44,594 | -29.2% | 0.00% | – |
Q3 2016 | $170,000 | +25.9% | 62,945 | +9.9% | 0.00% | – |
Q2 2016 | $135,000 | -81.8% | 57,268 | -75.0% | 0.00% | – |
Q1 2016 | $741,000 | -27.6% | 229,404 | +7.3% | 0.00% | – |
Q4 2015 | $1,024,000 | -37.6% | 213,726 | -27.5% | 0.00% | -100.0% |
Q3 2015 | $1,640,000 | -39.1% | 294,925 | -12.8% | 0.00% | 0.0% |
Q2 2015 | $2,693,000 | -71.6% | 338,307 | -62.5% | 0.00% | -50.0% |
Q1 2015 | $9,471,000 | -13.1% | 902,035 | -0.5% | 0.00% | -33.3% |
Q4 2014 | $10,898,000 | -34.3% | 906,580 | -6.5% | 0.00% | -25.0% |
Q3 2014 | $16,578,000 | -18.4% | 970,059 | -42.4% | 0.00% | +33.3% |
Q2 2014 | $20,320,000 | +747.0% | 1,683,508 | +492.2% | 0.00% | +200.0% |
Q1 2014 | $2,399,000 | +189.4% | 284,303 | +102.2% | 0.00% | – |
Q4 2013 | $829,000 | -52.6% | 140,616 | -56.3% | 0.00% | – |
Q3 2013 | $1,748,000 | +213.8% | 321,932 | +134.5% | 0.00% | – |
Q2 2013 | $557,000 | – | 137,261 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
1492 Capital Management LLC | 804,490 | $3,001,000 | 2.25% |
Rubric Capital Management LP | 4,000,000 | $14,920,000 | 1.39% |
KNOTT DAVID M | 481,930 | $1,798,000 | 1.06% |
Zebra Capital Management LLC | 132,442 | $494,000 | 0.76% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,405,342 | $12,702,000 | 0.70% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,635,750 | $28,481,000 | 0.69% |
Penn Capital Management Company, LLC | 1,252,079 | $4,670,000 | 0.59% |
Nantahala Capital Management | 5,065,955 | $18,896,000 | 0.58% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,602,385 | $5,977,000 | 0.26% |
EMERALD ADVISERS, LLC | 1,655,711 | $6,176,000 | 0.25% |